9don MSN
Georgia bill would allow pharmacists to prescribe PrEP in effort to expand HIV prevention access
A bill moving through the Georgia General Assembly could allow trained pharmacists to prescribe PrEP, a daily medication that can prevent HIV.
A U.S. District Court judge in Illinois granted a temporary restraining order to reinstate $602 million in public health grants allocated for four states that the Trump administration had moved to ...
Introduction Cryptococcal meningitis (CM) is an infection of the central nervous system that accounts for approximately 19% ...
The AAP 2026 schedule maintains status for vaccines the CDC moved to shared clinical decision-making, aiming to avoid clinician and parent confusion.
The Trump administration this week began cuts to $600 million in funding used to track and prevent HIV and STDs in four Democrat-led states. (Scripps News) Study of 27.8M Americans may have revealed ...
NORTH CHARLESTON, S.C. (WCIV) — National Black HIV/AIDS Awareness Day will be observed Saturday, Feb. 7, with local health advocates urging education, testing and stigma reduction to address the ...
By pairing digital tools with tailored HIV services delivered by community health workers and clinicians, a study has reduced new HIV cases by 70% in rural Kenya and Uganda. This successful strategic ...
In 2017, researchers in New Zealand published the first evidence that a vaccine might be able to prevent gonorrhea, a wily ...
MZUZU-(MaraviPost)-A shift in priorities by major donor countries toward wars in Ukraine, Iran, and parts of Africa—coupled with punitive legal frameworks—continues to undermine global efforts against ...
LILONGWE-(MaraviPost)-Malawi’s medical professionals are up in arms over President Arthur Peter Mutharika’s executive order restricting their right to engage in private practice. The order, which bans ...
On behalf of the United States, I offer my heartfelt congratulations to the citizens of The Gambia as you celebrate 61 years of independence. As you mark this important milestone, we reaffirm the ...
A phase 3 clinical trial, led by Professor Chloe Orkin of Queen Mary University of London, has shown that a new, daily oral tablet that combines two current HIV treatment medications – bictegravir and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results